Goldman Sachs Group »

Stoke Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $19M 1.4M 13.51
2024-03-31 $19M 1.4M 13.50
2023-12-31 $7.3M 1.4M 5.26
2023-09-30 $510k 129k 3.94
2023-06-30 $994k 94k 10.63
2023-03-31 $685k 82k 8.33
2022-12-31 $626k 68k 9.23
2022-06-30 $1.6M 122k 13.21
2022-03-31 $2.4M 114k 21.05
2021-12-31 $3.0M 126k 23.99
2021-09-30 $4.4M 173k 25.44
2021-03-31 $22M 558k 38.84
2020-12-31 $36M 577k 61.93
2020-09-30 $3.6M 109k 33.49
2020-06-30 $3.4M 143k 23.83
2019-12-31 $1.9M 68k 28.32
2019-09-30 $993k 46k 21.50
2019-06-30 $2.3M 80k 29.17